1-19 of 19
fludarabine
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

HLA-haploidentical TCRαβ + /CD19 + -depleted stem cell transplantation in children and young adults with Fanconi anemia

Clinical Trials & Observations
Luisa Strocchio, Daria Pagliara, Mattia Algeri, Giuseppina Li Pira, Francesca Rossi, Valentina Bertaina, Giovanna Leone, Rita Maria Pinto, Marco Andreani, Emanuele Agolini, Katia Girardi, Stefania Gaspari, Lavinia Grapulin, Francesca del Bufalo, Antonio Novelli, Pietro Merli, Franco Locatelli
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1333–1339.
https://doi.org/10.1182/bloodadvances.2020003707
Published: 2021
Journal Articles

Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia

Clinical Trials & Observations
Antonio Pierini, Loredana Ruggeri, Alessandra Carotti, Franca Falzetti, Simonetta Saldi, Adelmo Terenzi, Claudio Zucchetti, Gianluca Ingrosso, Tiziana Zei, Roberta Iacucci Ostini, Sara Piccinelli, Samanta Bonato, Sara Tricarico, Antonella Mancusi, Sara Ciardelli, Roberto Limongello, Mara Merluzzi, Mauro Di Ianni, Rita Tognellini, Olivia Minelli, Cristina Mecucci, Maria Paola Martelli, Brunangelo Falini, Massimo Fabrizio Martelli, Cynthia Aristei, Andrea Velardi
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1199–1208.
https://doi.org/10.1182/bloodadvances.2020003739
Published: 2021
Includes: Supplemental data
Journal Articles

Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial

Clinical Trials & Observations
Catia Simoes, Bruno Paiva, David Martínez-Cuadrón, Juan-Miguel Bergua, Susana Vives, Lorenzo Algarra, Mar Tormo, Pilar Martinez, Josefina Serrano, Pilar Herrera, Fernando Ramos, Olga Salamero, Esperanza Lavilla, Cristina Gil, Jose-Luis Lopez, Maria-Belen Vidriales, Jorge Labrador, Jose-Francisco Falantes, María-José Sayas, Rosa Ayala, Joaquin Martinez-Lopez, Sara Villar, Maria-Jose Calasanz, Felipe Prosper, Jesús F. San-Miguel, Miguel Ángel Sanz, Pau Montesinos
Journal: Blood Advances
Blood Adv (2021) 5 (3): 760–770.
https://doi.org/10.1182/bloodadvances.2020003195
Published: 2021
Includes: Supplemental data
Journal Articles

Abatacept is effective as GVHD prophylaxis in unrelated donor stem cell transplantation for children with severe sickle cell disease

Clinical Trials & Observations
Alexander Ngwube, Niketa Shah, Kamar Godder, David Jacobsohn, Monica L. Hulbert, Shalini Shenoy
Journal: Blood Advances
Blood Adv (2020) 4 (16): 3894–3899.
https://doi.org/10.1182/bloodadvances.2020002236
Published: 2020
Journal Articles

Treosulfan-based conditioning is feasible and effective for cord blood recipients: a phase 2 multicenter study

Clinical Trials & Observations
Filippo Milano, Jonathan A. Gutman, H. Joachim Deeg, Eneida R. Nemecek, Joachim Baumgart, Laurel Thur, Ann Dahlberg, Rachel B. Salit, Corinne Summers, Frederick R. Appelbaum, Colleen Delaney
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3302–3310.
https://doi.org/10.1182/bloodadvances.2020002222
Published: 2020
Includes: Supplemental data
Journal Articles

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report

Clinical Trials & Observations
Zheng Zhou, Rajneesh Nath, Jan Cerny, Hai-Lin Wang, Mei-Jie Zhang, Hisham Abdel-Azim, Vaibhav Agrawal, Gulrayz Ahmed, A. Samer Al-Homsi, Mahmoud Aljurf, Hassan B. Alkhateeb, Amer Assal, Ulrike Bacher, Ashish Bajel, Qaiser Bashir, Minocher Battiwalla, Vijaya Raj Bhatt, Michael Byrne, Jean-Yves Cahn, Mitchell Cairo, Hannah Choe, Edward Copelan, Corey Cutler, Moussab B. Damlaj, Zachariah DeFilipp, Marcos De Lima, Miguel Angel Diaz, Nosha Farhadfar, James Foran, César O. Freytes, Aaron T. Gerds, Usama Gergis, Michael R. Grunwald, Zartash Gul, Mehdi Hamadani, Shahrukh Hashmi, Mark Hertzberg, Gerhard C. Hildebrandt, Nasheed Hossain, Yoshihiro Inamoto, Luis Isola, Tania Jain, Rammurti T. Kamble, Muhammad Waqas Khan, Mohamed A. Kharfan-Dabaja, Partow Kebriaei, Natasha Kekre, Nandita Khera, Hillard M. Lazarus, Jane L. Liesveld, Mark Litzow, Hongtao Liu, David I. Marks, Rodrigo Martino, Vikram Mathews, Asmita Mishra, Hemant S. Murthy, Arnon Nagler, Ryotaro Nakamura, Sunita Nathan, Taiga Nishihori, Rebecca Olin, Richard F. Olsson, Neil Palmisiano, Sagar S. Patel, Mrinal M. Patnaik, Attaphol Pawarode, Miguel-Angel Perales, Ioannis Politikos, Uday Popat, David Rizzieri, Brenda M. Sandmaier, Bipin N. Savani, Sachiko Seo, Nirav N. Shah, Geoffrey L. Uy, David Valcárcel, Leo F. Verdonck, Edmund K. Waller, Youjin Wang, Daniel Weisdorf, Baldeep Wirk, Eric Wong, Jean A. Yared, Wael Saber
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3180–3190.
https://doi.org/10.1182/bloodadvances.2019001266
Published: 2020
Includes: Supplemental data
Journal Articles

Reduced-intensity single-unit unrelated cord blood transplant with optional immune boost for nonmalignant disorders

Clinical Trials & Observations
Mark T. Vander Lugt, Xiaohua Chen, Maria L. Escolar, Beth A. Carella, Jessie L. Barnum, Randy M. Windreich, Memphis J. Hill, Michelle Poe, Rebecca A. Marsh, Heather Stanczak, Elizabeth O. Stenger, Paul Szabolcs
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3041–3052.
https://doi.org/10.1182/bloodadvances.2020001940
Published: 2020
Includes: Supplemental data
Journal Articles

Targeted busulfan-based reduced-intensity conditioning and HLA-matched HSCT cure hemophagocytic lymphohistiocytosis

Clinical Trials & Observations
Matthias Felber, Colin G. Steward, Karim Kentouche, Anders Fasth, Robert F. Wynn, Ulrike Zeilhofer, Veronika Haunerdinger, Benjamin Volkmer, Seraina Prader, Bernd Gruhn, Stephan Ehl, Kai Lehmberg, Daniel Müller, Andrew R. Gennery, Michael H. Albert, Fabian Hauck, Kanchan Rao, Paul Veys, Moustapha Hassan, Arjan C. Lankester, Jana Pachlopnik Schmid, Mathias M. Hauri-Hohl, Tayfun Güngör
Journal: Blood Advances
Blood Adv (2020) 4 (9): 1998–2010.
https://doi.org/10.1182/bloodadvances.2020001748
Published: 2020
Includes: Supplemental data
Journal Articles

The Connect CLL Registry: final analysis of 1494 patients with chronic lymphocytic leukemia across 199 US sites

Clinical Trials & Observations
Anthony Mato, Chadi Nabhan, Nicole Lamanna, Neil E. Kay, David L. Grinblatt, Christopher R. Flowers, Charles M. Farber, Matthew S. Davids, Arlene S. Swern, Kristen Sullivan, E. Dawn Flick, Sarah M. Gressett Ussery, Mecide Gharibo, Pavel Kiselev, Jeff P. Sharman
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1407–1418.
https://doi.org/10.1182/bloodadvances.2019001145
Published: 2020
Includes: Supplemental data
Journal Articles

Targeting CD300f to enhance hematopoietic stem cell transplantation in acute myeloid leukemia

Edward Abadir, Pablo A. Silveira, Robin E. Gasiorowski, Murari Ramesh, Adelina Romano, Ahmed H. Mekkawy, Tsun-Ho Lo, Karieshma Kabani, Sarah Sutherland, Geoffrey A. Pietersz, P. Joy Ho, Christian E. Bryant, Stephen R. Larsen, Georgina J. Clark
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1206–1216.
https://doi.org/10.1182/bloodadvances.2019001289
Published: 2020
Includes: Supplemental data
Journal Articles

Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 years

Vipul Sharad Sheth, Victoria Potter, Shreyans A. Gandhi, Austin Gladston Kulasekararaj, Hugues de Lavallade, Petra Muus, Antonio Pagliuca, Carmel F. M. Rice, Varun Mehra, Francesco Grimaldi, Shafqat Inam, Linda D. Barber, Ghulam J. Mufti, Judith C. Marsh
Journal: Blood Advances
Blood Adv (2019) 3 (20): 3070–3079.
https://doi.org/10.1182/bloodadvances.2019000480
Published: 2019
Includes: Supplemental data
Journal Articles

Fludarabine exposure in the conditioning prior to allogeneic hematopoietic cell transplantation predicts outcomes

Clinical Trials & Observations
J. B. Langenhorst, C. van Kesteren, E. M. van Maarseveen, T. P. C. Dorlo, S. Nierkens, C. A. Lindemans, M. A. de Witte, A. van Rhenen, R. Raijmakers, M. Bierings, J. Kuball, A. D. R. Huitema, J. J. Boelens
Journal: Blood Advances
Blood Adv (2019) 3 (14): 2179–2187.
https://doi.org/10.1182/bloodadvances.2018029421
Published: 2019
Journal Articles

Haploidentical vs haplo-cord transplant in adults under 60 years receiving fludarabine and melphalan conditioning

Clinical Trials & Observations
Koen van Besien, Andrew Artz, Richard E. Champlin, Danielle Guarneri, Michael R. Bishop, Julianne Chen, Usama Gergis, Tsiporah Shore, Hongtao Liu, Gabriela Rondon, Sebastian A. Mayer, Samer A. Srour, Wendy Stock, Stefan O. Ciurea
Journal: Blood Advances
Blood Adv (2019) 3 (12): 1858–1867.
https://doi.org/10.1182/bloodadvances.2019000200
Published: 2019
Journal Articles

Immune cytopenia post–cord transplant in Hurler syndrome is a forme fruste of graft rejection

David Deambrosis, Su Han Lum, Ryan M. Hum, Kay Poulton, Wendy Ogden, Simon Jones, Simon Stanworth, Denise Bonney, Prashant Hiwarkar, Robert F. Wynn
Journal: Blood Advances
Blood Adv (2019) 3 (4): 570–574.
https://doi.org/10.1182/bloodadvances.2018026963
Published: 2019
Includes: Supplemental data
Journal Articles

MIPSS70+ v2.0 predicts long-term survival in myelofibrosis after allogeneic HCT with the Flu/Mel conditioning regimen

Clinical Trials & Observations
Haris Ali, Ibrahim Aldoss, Dongyun Yang, Sally Mokhtari, Samer Khaled, Ahmed Aribi, Michelle Afkhami, Monzr M. Al Malki, Thai Cao, Matthew Mei, Margaret O’Donnell, Amandeep Salhotra, Vinod Pullarkat, Lixin Yang, Anthony S. Stein, Guido Marcucci, Stephen J. Forman, Ryotaro Nakamura, Raju Pillai, David Snyder
Journal: Blood Advances
Blood Adv (2019) 3 (1): 83–95.
https://doi.org/10.1182/bloodadvances.2018026658
Published: 2019
Includes: Supplemental data
Journal Articles

Hematopoietic cell transplant for acute myeloid leukemia and myelodysplastic syndrome: conditioning regimen intensity

Clinical Trials & Observations
Mary Eapen, Ruta Brazauskas, Michael Hemmer, Waleska S. Perez, Patricia Steinert, Mary M. Horowitz, H. Joachim Deeg
Journal: Blood Advances
Blood Adv (2018) 2 (16): 2095–2103.
https://doi.org/10.1182/bloodadvances.2018021980
Published: 2018
Journal Articles

Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine

Clinical Trials & Observations
Andrew C. Harris, Jaap J. Boelens, Kwang Woo Ahn, Mingwei Fei, Allistair Abraham, Andrew Artz, Christopher Dvorak, Haydar Frangoul, Cesar Freytes, Robert Peter Gale, Sanghee Hong, Hillard M. Lazarus, Alison Loren, Shin Mineishi, Taiga Nishihori, Tracey O’Brien, Kirsten Williams, Marcelo C. Pasquini, John E. Levine
Journal: Blood Advances
Blood Adv (2018) 2 (11): 1198–1206.
https://doi.org/10.1182/bloodadvances.2018016956
Published: 2018
Includes: Supplemental data
Journal Articles

Early progression of disease as a predictor of survival in chronic lymphocytic leukemia

Clinical Trials & Observations
Inhye E. Ahn, Charles M. Farber, Matthew S. Davids, David L. Grinblatt, Neil E. Kay, Nicole Lamanna, Anthony Mato, Chadi Nabhan, Pavel Kiselev, Arlene S. Swern, E. Dawn Flick, Kristen Sullivan, Jeff P. Sharman, Christopher R. Flowers
Journal: Blood Advances
Blood Adv (2017) 1 (25): 2433–2443.
https://doi.org/10.1182/bloodadvances.2017011262
Published: 2017
Includes: Supplemental data
Journal Articles

Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide

Clinical Trials & Observations
Yvette L. Kasamon, Richard F. Ambinder, Ephraim J. Fuchs, Marianna Zahurak, Gary L. Rosner, Javier Bolaños-Meade, Mark J. Levis, Douglas E. Gladstone, Carol Ann Huff, Lode J. Swinnen, William H. Matsui, Ivan Borrello, Robert A. Brodsky, Richard J. Jones, Leo Luznik
Journal: Blood Advances
Blood Adv (2017) 1 (4): 288–292.
https://doi.org/10.1182/bloodadvances.2016002766
Published: 2017
Includes: Supplemental data